Genmab

	15/9 11:35 af Plimsoller	Just elaborating after she had a second look. it says that the company got persmission from the government to perform the trials. It basically means that the company must have submitted the request to the government bureau beforehand.
	15/9 11:26 af E L	haha
	15/9 11:26 af Plimsoller	:-)
	15/9 11:26 af Plimsoller	No problem. She is quite impressed that a Dutch guy who doesn't speak Chinese found that article :D
	15/9 11:25 af E L	ok, thanks. and thanks to your colleague ;-)
	15/9 11:24 af Plimsoller	Yes.
	15/9 11:23 af E L	permission for what ? to do the trial?
	15/9 11:22 af Plimsoller	I used Google myself (thought you had issued with their translator), but I just asked a Chinese colleague that question, and she said that they are saying that they have permission.
	15/9 11:18 af E L	Did they get permission to do those 4 trials in China ? is that what they are saying?
	15/9 11:17 af E L	thanks, got them, similar to what i get with google tranlator, however wasn't sure what that actually means?
	15/9 11:13 af Plimsoller	That didn't go to well :-) Hang on - will send you another one.
	15/9 11:07 af Plimsoller	Sent you a PM E L.
	15/9 10:34 af E L	could use some help on the translation of this chinese article on Amivantamab... (link)
	15/9 09:50 af Helge Larsen/PI-redaktør	Yes. :-)
	15/9 09:28 af E L	ok. I guess we find out next week ;-)
	15/9 09:27 af Helge Larsen/PI-redaktør	I receive Symphony Health data from pharma- og biotech investors. I dont know anything about af a evnt. split in Dara IV and Dara Faspro.
	15/9 09:21 af Helge Larsen/PI-redaktør	Sorry..Link to tweet. (link)
	15/9 09:16 af E L	I was just wondering Helge, I don't know who you normally get the Symphony Health data from, but should we expect 1 number for Dara, or a split in Dara IV and Dara Faspro?
	15/9 09:14 af E L	that link doesn't get you much, you may want to put the link to the tweet?
	15/9 09:11 af Helge Larsen/PI-redaktør	Genmab @Genmab Join us at ESMO20, for an oral presentation on phase 2 innovaTV 204 study evaluating the investigational tisotumab vedotin in patients with recurrent or metastatic #cervicalcancer. Visit our virtual booth to get more info. (link)
	15/9 08:05 af transalp	Go morgen.. :)
	15/9 06:55 af bibob	God morgen :-)
	15/9 06:49 af Helge Larsen/PI-redaktør	God morgen. :-)
	14/9 19:45 af GeorgeBest	og igen side 66-68 / Roche har fart på, SC version præsenteres på ASH!

	14/9 19:42 af GeorgeBest	Mosunetuzumab and glofitamab (CD20xCD3) Potential first in class bispecifics in DLBCL and FL - se side 44 (link)
	14/9 19:41 af Helge Larsen/PI-redaktør	amyloidosis Research Consortium @Amyloidosis_ARC · 3 t Game changer for AL amyloidosis -Janssen Pharmaceutical has filed an application with the US Food and Drug Administration seeking approval for Darzalex Faspro to treat light chain (AL) amyloidosis. (link)
	14/9 19:40 af GeorgeBest	Roche Pharma Day 2020 presentation (link)
	14/9 17:51 af Solsen	Vi ved at JW har ambition om at blive et stort pharma med Genmab a la Regeneron eller Amgen. Hhv $60 og $145 bn....
	14/9 16:27 af Solsen	Godt vi så ved at JW siger, at I ikke skal sælge ;-)
	14/9 16:11 af nohope	Ja, eller 2200
	14/9 15:21 af Solsen	...deals
	14/9 14:53 af Solsen	More ADC reals - SGEN and Merck (link)
	14/9 13:38 af Helge Larsen/PI-redaktør	Stockbull...Jeg tænker ud fra citatet ikke på aktiemarkedet, men alene realøkonomien.
	14/9 13:20 af E L	SpringWorks already works with GSK on belantamab
	14/9 13:17 af E L	(link)
	14/9 13:16 af E L	SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
	14/9 13:16 af E L	and another one, this time we are involved
	14/9 13:15 af E L	money is for free,they'll never run out of it ;-)
	14/9 13:00 af nohope	Fuck - BPx will run out of money before we get a decent +110 % offer for GEN.
	14/9 12:56 af E L	another deal- Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations (link) SGEN up 17% pre-market
	14/9 12:35 af gentogen	Thanks EL. Sounds good: "an oral presentation and live Q&A of the latest data from the Phase 1 dose escalation study investigating amivantamab " (from your link)
	14/9 11:18 af StockBull	Enig Helge 8:31. Men husk på aktiemarkedet er som regel 6-9 måneder foran så det kunne tyde på markeded mener vi er over det værste. Så umidlbart tror jeg man skal supplere til den langsigtede beholdning på de retracements som kommer jævnligt
	14/9 08:59 af E L	Janssen to Present Key Data from Across Its Expansive Oncology Portfolio at ESMO 2020 Virtual Congress - Safety and efficacy data from the Phase 1 CHRYSALIS study exploring amivantamab in combination with lazertinib in patients with advanced EGFR-mutated NSCLC (link)
	14/9 08:51 af E L	will be interesting to see what valuations do this week for other biotechs with ADC's in their portfolio after the Immunicum news...
	14/9 08:31 af Helge Larsen/PI-redaktør	Vi skal først have overstået alt det med med coronavirus og dens senfølger på økonomien.
	14/9 07:36 af StockBull	Beder man Nikolaj Schmidt sætte en tidsramme på opsvinget, vurderer han, at vi står over for fem til otte år med positiv vækst, før man igen skal frygte en decideret recession som den, der ramte den globale økonomi i første og andet kvartal i år.
	14/9 07:35 af StockBull	Morn :-) Globalt opsving (link)
	14/9 07:01 af Helge Larsen/PI-redaktør	Vincent Rajkumar @VincentRK · 2 t 4 key slides from my talk on “How I Treat Newly Diagnosed Myeloma” at(link)
	14/9 06:58 af transalp	Go morgen .. :)
	14/9 06:48 af bibob	God morgen. :-)